Re: Question about publications - Nature
|
4
|
Resverlogix Corp.
|
Feb 12, 2022 10:58AM
|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 03:10PM
|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 01:35PM
|
Re: Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 01:23PM
|
Question about publications - Nature
|
1
|
Resverlogix Corp.
|
Feb 11, 2022 12:32PM
|
Re: Not good for the potential of apabetalone as a Covid-19 therapy
|
2
|
Resverlogix Corp.
|
Dec 01, 2021 04:59PM
|
Re: Nine Months, 2021- Financials and MD&A on SEDAR
|
1
|
Resverlogix Corp.
|
Nov 13, 2021 02:34PM
|
News Release
|
7
|
Resverlogix Corp.
|
Sep 13, 2021 08:49AM
|
Re: BETonMACE Cognition Sub-Study Published
|
7
|
Resverlogix Corp.
|
Sep 01, 2021 12:36PM
|
What is RVX worth?? - Constellation taken over (CNST)
|
2
|
Resverlogix Corp.
|
Jun 02, 2021 09:02AM
|
Re: Wow! Quite the read!
|
6
|
Resverlogix Corp.
|
May 30, 2021 09:48AM
|
Q1 financials posted
|
2
|
Resverlogix Corp.
|
May 17, 2021 10:34PM
|
Re: COVID trial now in CTD
|
3
|
Resverlogix Corp.
|
May 15, 2021 12:23PM
|
Re: For those who missed it live...
|
2
|
Resverlogix Corp.
|
May 13, 2021 10:51AM
|
Re: Todays presentation - Archman and paladin
|
9
|
Resverlogix Corp.
|
May 12, 2021 02:38PM
|
Re: RESVERLOGIX CORP WTS 2021
|
1
|
Resverlogix Corp.
|
May 11, 2021 05:21PM
|
Re: Resverlogix announces HEPALINK debenture $6mill
|
4
|
Resverlogix Corp.
|
May 05, 2021 10:18AM
|
Farxiga (SGLT2i) approved for CKD patients with AND without T2D
|
4
|
Resverlogix Corp.
|
May 01, 2021 03:33PM
|
Re: Management performance
|
10
|
Resverlogix Corp.
|
Apr 27, 2021 12:49PM
|
Re: Shorts
|
3
|
Resverlogix Corp.
|
Apr 26, 2021 03:12PM
|